Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial: commentary, author response
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial: commentary, author response - Volume 226 Issue 5
Authors
- Colleen Loo (ORCID: https://orcid.org/0000-0003-3267-0554)
- Shanthi Sarma (ORCID: https://orcid.org/0000-0003-0113-7415)
- Angelo Alonzo (ORCID: https://orcid.org/0000-0003-3304-4387)
- Anthony Rodgers (ORCID: https://orcid.org/0000-0003-1282-1896)
- Natalie Mills (ORCID: https://orcid.org/0000-0003-3255-5118)
- Mary Lou Chatterton (ORCID: https://orcid.org/0000-0003-4902-9448)
- Vanessa Dong (ORCID: https://orcid.org/0009-0004-7918-3782)
- Dávid Barton (ORCID: https://orcid.org/0000-0002-7074-3825)
- Michael Berk (ORCID: https://orcid.org/0000-0002-5554-6946)
- Andrew A. Somogyi (ORCID: https://orcid.org/0000-0003-4779-0380)
- Philip Bowden Mitchell (ORCID: https://orcid.org/0000-0002-7954-5235)
- Verònica Gálvez
Institutions
- Bond University (AU)
- Barwon Health (AU)
- Deakin University (AU)
- Black Dog Institute (AU)
- UNSW Sydney (AU)
- Melbourne Sexual Health Centre (AU)
- The George Institute for Global Health (AU)
- Institute of Research and Innovation Parc Tauli (ES)
- Gold Coast Health (AU)
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1192/bjp.2024.176
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39